Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure

被引:45
作者
Badary, Osama A. [1 ,2 ]
Hamza, Marwa S. [1 ]
Tikamdas, Rajiv [1 ]
机构
[1] British Univ Egypt, Fac Pharm, Clin Pharm Practice Dept, POB 43, Cairo 11837, Egypt
[2] Ain Shams Univ, Fac Pharm, Clin Pharm Dept, Cairo, Egypt
来源
DRUG DESIGN DEVELOPMENT AND THERAPY | 2021年 / 15卷
关键词
thymoquinone; COVID-19; natural; therapeutic benefits; NIGELLA-SATIVA L; NANOSTRUCTURED LIPID CARRIER; OXIDATIVE STRESS; ISCHEMIA-REPERFUSION; GENE-EXPRESSION; CONSTITUENT THYMOQUINONE; ORAL BIOAVAILABILITY; MAJOR CONSTITUENT; SIGNALING PATHWAY; ACTIVE COMPONENT;
D O I
10.2147/DDDT.S308863
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
COVID-19 has caused a major global health crisis, as excessive inflammation, oxidation, and exaggerated immune response in some sufferers can lead to a condition known as cytokine storm, which may progress to acute respiratory distress syndrome (ARDs), which can be fatal. So far, few effective drugs have emerged to assist in the treatment of patients with COVID-19, though some herbal medicine candidates may assist in the fight against COVID-19 deaths. Thymoquinone (TQ), the main active ingredient of black seed oil, possesses antioxidant, anti-inflammatory, antiviral, antimicrobial, immuno-modulatory and anticoagulant activities. TQ also increases the activity and number of cytokine suppressors, lymphocytes, natural killer cells, and macrophages, and it has demon-strated antiviral potential against a number of viruses, including murine cytomegalovirus, Epstein-Barr virus, hepatitis C virus, human immunodeficiency virus, and other corona-viruses. Recently, TQ has demonstrated notable antiviral activity against a SARSCoV-2 strain isolated from Egyptian patients and, interestingly, molecular docking studies have also shown that TQ could potentially inhibit COVID-19 development through binding to the receptor-binding domain on the spike and envelope proteins of SARS-CoV-2, which may hinder virus entry into the host cell and inhibit its ion channel and pore forming activity. Other studies have shown that TQ may have an inhibitory effect on SARS CoV2 proteases, which could diminish viral replication, and it has also demonstrated good antagonism to angiotensin-converting enzyme 2 receptors, allowing it to interfere with virus uptake into the host cell. Several studies have also noted its potential protective capability against numerous chronic diseases and conditions, including diabetes, hypertension, dyslipidemia, asthma, renal dysfunction and malignancy. TQ has recently been tested in clinical trials for the treatment of several different diseases, and this review thus aims to highlight the potential therapeutic effects of TQ in the context of the COVID-19 pandemic.
引用
收藏
页码:1819 / 1833
页数:15
相关论文
共 203 条
  • [31] Anti-Inflammatory and Neuroprotective Effects of Triptolide via the NF-κB Signaling Pathway in a Rat MCAO Model
    Bai, Shi
    Hu, Zhiying
    Yang, Yang
    Yin, Yifei
    Li, Weiyun
    Wu, Lijuan
    Fang, Marong
    [J]. ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2016, 299 (02): : 256 - 266
  • [32] Thymoquinone alleviates thioacetamide-induced hepatic fibrosis and inflammation by activating LKB1-AMPK signaling pathway in mice
    Bai, Ting
    Yang, Yong
    Wu, Yan-Ling
    Jiang, Shuang
    Lee, Jung Joon
    Lian, Li-Hua
    Nan, Ji-Xing
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 19 (02) : 351 - 357
  • [33] Bakhtiar L, 1999, CANON MED AL QANUN F
  • [34] Effects of Nigella sativa on outcome of hepatitis C in Egypt
    Barakat, Eman Mahmoud Fathy
    El Wakeel, Lamia Mohamed
    Hagag, Radwa Samir
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (16) : 2529 - 2536
  • [35] Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats
    Basarslan, F.
    Yilmaz, N.
    Ates, S.
    Ozgur, T.
    Tutanc, M.
    Motor, V. K.
    Arica, V.
    Yilmaz, C.
    Inci, M.
    Buyukbas, S.
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 2012, 31 (07) : 726 - 733
  • [36] Mast cell myositis: a new feature of allergic asthma?
    Berger, P
    Girodet, PO
    Tunon-de-Lara, JM
    [J]. ALLERGY, 2005, 60 (10) : 1238 - 1240
  • [37] What is oxidative stress?
    Betteridge, DJ
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (02): : 3 - 8
  • [38] Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
    Bindu, Samik
    Mazumder, Somnath
    Bandyopadhyay, Uday
    [J]. BIOCHEMICAL PHARMACOLOGY, 2020, 180
  • [39] Oxidative Stress and Antioxidant Defense
    Birben, Esra
    Sahiner, Umit Murat
    Sackesen, Cansin
    Erzurum, Serpil
    Kalayci, Omer
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2012, 5 : 9 - 19
  • [40] Bouchentouf S, 2020, MOL DOCKING STUDY